Clinical Evaluation of EUS-FNA on Diagnosis of Pancreatic Cystic Lesions
- Conditions
- Pancreatic Cyst
- Interventions
- Procedure: EUS-FNA
- Registration Number
- NCT02041897
- Lead Sponsor
- Xiaoyin Zhang
- Brief Summary
It is still controversial about the necessity of endoscopy ultrasound guide fine needle aspiration (EUS-FNA) on diagnosis of pancreatic cystic lesions(PCL).The aim of this study is to find the influence of EUS-FNA on diagnosis and suggestions of EUS specialists.
- Detailed Description
First, the investigators will send only EUS images of patients with PCL to diagnosis committee that is consisted with 8 EUS specialists from different countries.The diagnosis will be collected. Then the investigators send the results of EUS-FNA. The diagnosis and suggestions will be collected again. The investigators will calculate how much diagnosis has been changed because of results of EUS-FNA. The investigators will also follow up these patients for 5 years at least to find if these patients benefit from EUS-FNA and complications such as needle tract seeding metastases.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 160
- Adults with ages from 18-80 years old.
- The patients with pancreatic cystic lesions, which diameter of cystic lesion more than 2cm.
- Sign the informed consent voluntarily. -
-
The patient can't accept the endoscopic procedure.
-
The patient has blood coagulation dysfunction.
-
The patient has mental disorders.
-
The patient has mild or severe cardiorespiratory insufficiency.
-
The patient has hypertension and can't be controlled to safe level.
-
Patients with alcohol dependence.
-
Pregnant and lactating women.
-
The patients the investigators don't think suitable for this study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description EUS-FNA, Rate of chang on diagnosis EUS-FNA It is a single arm study. We will conclude by calculating the rate of change of diagnosis before and after getting the results of EUS-FNA.
- Primary Outcome Measures
Name Time Method Rate of change of diagnosis During 2 weeks Finish diagnosis before and after getting the results of EUS-FNA
- Secondary Outcome Measures
Name Time Method Number of Participants with Adverse Events 5 years after EUS-FNA
Trial Locations
- Locations (1)
Department of Gastroenterology,Xijing Hospital
🇨🇳Xian, Shanxi, China